Tetanus Toxoid Vaccine Global Market Report 2024

Description

The tetanus toxoid vaccine is designed to prevent tetanus, a severe bacterial infection caused by Clostridium tetani. It contains a form of the tetanus toxin, known as toxoid, which is harmless but prompts the immune system to generate antibodies against the toxin. These antibodies work by neutralizing the toxin produced by the bacteria, thereby providing protection against future infections.

The various types of tetanus toxoid vaccines are available. These include tetanus toxoid (Tt), diphtheria and tetanus (Dt), tetanus and diphtheria (Td), diphtheria, tetanus, and pertussis (Dtap), tetanus, diphtheria, and pertussis (Tdap), pentavalent, hexavalent, and others. Tetanus toxoid (Tt) vaccines consist of purified tetanus toxoid that stimulates the immune system to defend against tetanus-causing bacteria. These vaccines are used across different age groups, from pediatric to adult, in hospitals, clinics, government organizations, and other healthcare settings.

The tetanus toxoid vaccine market research report is one of a series of new reports from The Business Research Company that provides tetanus toxoid vaccine market statistics, including the tetanus toxoid vaccine industry global market size, regional shares, competitors with tetanus toxoid vaccine market share, detailed tetanus toxoid vaccine market segments, market trends, and opportunities, and any further data you may need to thrive in the tetanus toxoid vaccine industry. These tetanus toxoid vaccine market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The tetanus toxoid vaccine market size has grown strongly in recent years. It will grow from $4.74 billion in 2023 to $5.08 billion in 2024 at a compound annual growth rate (CAGR) of 7.2%. The growth observed in the historic period can be attributed to several factors, including heightened awareness, a rise in tetanus cases, and government initiatives aimed at immunization programs.

The tetanus toxoid vaccine market size is expected to see strong growth in the next few years. It will grow to $6.74 billion in 2028 at a compound annual growth rate (CAGR) of 7.3%. The anticipated growth in the forecast period can be attributed to heightened investments in research and development, along with the expansion of distribution networks. Key trends expected during this period include advancements in vaccine technology, the emergence of new markets, the introduction of innovative products and services, and a rising demand for vaccines.

The tetanus toxoid vaccine market is expected to grow due to increasing rates of preterm births. Preterm birth, occurring before 37 weeks of gestation, presents health challenges due to incomplete development. Factors contributing to this issue include advanced maternal age, lifestyle choices, medical interventions such as assisted reproductive technologies, maternal health conditions, and environmental factors. The rise in preterm birth rates drives demand for tetanus toxoid vaccines as more newborns and infants require immunization against tetanus and other preventable diseases. For example, the Office for National Statistics reported a slight increase in the percentage of preterm live births from 7.4% in 2020 to 7.5% in 2021 in the UK, highlighting the trend driving the tetanus toxoid vaccine market growth.

Leading companies in the tetanus toxoid vaccine market are focusing on developing advanced vaccines, such as the wP-IPV-based pentavalent vaccine, to meet increasing demand for comprehensive immunization solutions. The wP-IPV-based pentavalent vaccine combines multiple disease protections into a single injection, using inactivated bacteria and viruses to stimulate immunity without causing illness. For instance, Panacea Biotec Limited launched EasyFourPol in December 2023, a fully-liquid pentavalent vaccine that protects against Diphtheria, Tetanus, Pertussis, Polio, and Haemophilus Influenza Type B infections. This vaccine simplifies administration by eliminating the need for on-site preparation, ensuring efficient and effective immunization.

In March 2021, Stablepharma Ltd. partnered with BB-NCIPD Ltd. to develop a thermally stable, fridge-free version of the tetanus-diphtheria (Td) vaccine using Stablepharma's patented StablevaX formulation and device technology. This collaboration aims to enhance vaccine accessibility and stability, particularly in regions with limited refrigeration infrastructure. BB-NCIPD Ltd., based in Bulgaria, specializes in vaccine production, including the Tetanus Toxoid vaccine.

Major companies operating in the tetanus toxoid vaccine market are Sanofi S.A., Novartis AG, LG Chem Ltd., GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Merck KGaA, Astellas Pharma Inc., CSL Limited, Zoetis Inc., Meiji Holdings Company Ltd., Walvax Biotechnology, Shenzhen Kangtai Biological Products Co. Ltd., AJ Vaccines AS, PT Bio Farma, Serum Institute of India Pvt. Ltd., Bharat Biotech International Limited, Panacea Biotec Ltd., Amson Vaccines and Pharma Pvt Ltd., Incepta Vaccine Ltd., Mitsubishi Tanabe Pharma Corporation, BioNet-Asia Co. Ltd., Avalon Pharma Pvt. Ltd., Actiza Pharmaceutical Pvt. Ltd

North America was the largest region in the tetanus toxoid vaccine market in 2023. The regions covered in the tetanus toxoid vaccine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the tetanus toxoid vaccine market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The tetanus toxoid vaccine market consists of sales of live, attenuated, inactivated, subunit, conjugate, and toxoid vaccines. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Tetanus Toxoid Vaccine Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on tetanus toxoid vaccine market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for tetanus toxoid vaccine ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The tetanus toxoid vaccine market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Vaccine Type: Tetanus Toxoid (TT); Diphtheria And Tetanus (DT); Tetanus And Diphtheria (Td); Diphtheria, Tetanus, And Pertussis (Dtap); Tetanus, Diphtheria, And Pertussis (Tdap); Pentavalent; Hexavalent; Other Types
2) By Age Group: Pediatric; Adult
3) By End-User: Hospitals And Clinics; Government Organizations; Other End-Users
Companies Mentioned: Sanofi S.A.; Novartis AG; LG Chem Ltd.; GlaxoSmithKline plc; Takeda Pharmaceutical Company Limited
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r19498

1. Executive Summary

2. Tetanus Toxoid Vaccine Market Characteristics

3. Tetanus Toxoid Vaccine Market Trends And Strategies

4. Tetanus Toxoid Vaccine Market - Macro Economic Scenario

4.1. Impact Of High Inflation On The Market
4.2. Ukraine-Russia War Impact On The Market
4.3. COVID-19 Impact On The Market

5. Global Tetanus Toxoid Vaccine Market Size and Growth

5.1. Global Tetanus Toxoid Vaccine Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
5.2. Global Tetanus Toxoid Vaccine Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Tetanus Toxoid Vaccine Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Tetanus Toxoid Vaccine Market Segmentation

6.1. Global Tetanus Toxoid Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Tetanus Toxoid (TT)
Diphtheria And Tetanus (DT)
Tetanus And Diphtheria (Td)
Diphtheria, Tetanus, And Pertussis (Dtap)
Tetanus, Diphtheria, And Pertussis (Tdap)
Pentavalent
Hexavalent
Other Types
6.2. Global Tetanus Toxoid Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Pediatric
Adult
6.3. Global Tetanus Toxoid Vaccine Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Hospitals And Clinics
Government Organizations
Other End-Users

7. Tetanus Toxoid Vaccine Market Regional And Country Analysis

7.1. Global Tetanus Toxoid Vaccine Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Tetanus Toxoid Vaccine Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Tetanus Toxoid Vaccine Market

8.1. Asia-Pacific Tetanus Toxoid Vaccine Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Tetanus Toxoid Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Tetanus Toxoid Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Tetanus Toxoid Vaccine Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Tetanus Toxoid Vaccine Market

9.1. China Tetanus Toxoid Vaccine Market Overview
9.2. China Tetanus Toxoid Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Tetanus Toxoid Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Tetanus Toxoid Vaccine Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Tetanus Toxoid Vaccine Market

10.1. India Tetanus Toxoid Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Tetanus Toxoid Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Tetanus Toxoid Vaccine Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Tetanus Toxoid Vaccine Market

11.1. Japan Tetanus Toxoid Vaccine Market Overview
11.2. Japan Tetanus Toxoid Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Tetanus Toxoid Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Tetanus Toxoid Vaccine Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Tetanus Toxoid Vaccine Market

12.1. Australia Tetanus Toxoid Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Tetanus Toxoid Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Tetanus Toxoid Vaccine Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Tetanus Toxoid Vaccine Market

13.1. Indonesia Tetanus Toxoid Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Tetanus Toxoid Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Tetanus Toxoid Vaccine Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Tetanus Toxoid Vaccine Market

14.1. South Korea Tetanus Toxoid Vaccine Market Overview
14.2. South Korea Tetanus Toxoid Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Tetanus Toxoid Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Tetanus Toxoid Vaccine Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Tetanus Toxoid Vaccine Market

15.1. Western Europe Tetanus Toxoid Vaccine Market Overview
15.2. Western Europe Tetanus Toxoid Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Tetanus Toxoid Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Tetanus Toxoid Vaccine Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Tetanus Toxoid Vaccine Market

16.1. UK Tetanus Toxoid Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Tetanus Toxoid Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Tetanus Toxoid Vaccine Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Tetanus Toxoid Vaccine Market

17.1. Germany Tetanus Toxoid Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Tetanus Toxoid Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Tetanus Toxoid Vaccine Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Tetanus Toxoid Vaccine Market

18.1. France Tetanus Toxoid Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Tetanus Toxoid Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Tetanus Toxoid Vaccine Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Tetanus Toxoid Vaccine Market

19.1. Italy Tetanus Toxoid Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Tetanus Toxoid Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Tetanus Toxoid Vaccine Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Tetanus Toxoid Vaccine Market

20.1. Spain Tetanus Toxoid Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Tetanus Toxoid Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Tetanus Toxoid Vaccine Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Tetanus Toxoid Vaccine Market

21.1. Eastern Europe Tetanus Toxoid Vaccine Market Overview
21.2. Eastern Europe Tetanus Toxoid Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Tetanus Toxoid Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Tetanus Toxoid Vaccine Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Tetanus Toxoid Vaccine Market

22.1. Russia Tetanus Toxoid Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Tetanus Toxoid Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Tetanus Toxoid Vaccine Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Tetanus Toxoid Vaccine Market

23.1. North America Tetanus Toxoid Vaccine Market Overview
23.2. North America Tetanus Toxoid Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Tetanus Toxoid Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Tetanus Toxoid Vaccine Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Tetanus Toxoid Vaccine Market

24.1. USA Tetanus Toxoid Vaccine Market Overview
24.2. USA Tetanus Toxoid Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Tetanus Toxoid Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Tetanus Toxoid Vaccine Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Tetanus Toxoid Vaccine Market

25.1. Canada Tetanus Toxoid Vaccine Market Overview
25.2. Canada Tetanus Toxoid Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Tetanus Toxoid Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Tetanus Toxoid Vaccine Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Tetanus Toxoid Vaccine Market

26.1. South America Tetanus Toxoid Vaccine Market Overview
26.2. South America Tetanus Toxoid Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Tetanus Toxoid Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Tetanus Toxoid Vaccine Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Tetanus Toxoid Vaccine Market

27.1. Brazil Tetanus Toxoid Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Tetanus Toxoid Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Tetanus Toxoid Vaccine Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Tetanus Toxoid Vaccine Market

28.1. Middle East Tetanus Toxoid Vaccine Market Overview
28.2. Middle East Tetanus Toxoid Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Tetanus Toxoid Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Tetanus Toxoid Vaccine Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Tetanus Toxoid Vaccine Market

29.1. Africa Tetanus Toxoid Vaccine Market Overview
29.2. Africa Tetanus Toxoid Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Tetanus Toxoid Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Tetanus Toxoid Vaccine Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Tetanus Toxoid Vaccine Market Competitive Landscape And Company Profiles

30.1. Tetanus Toxoid Vaccine Market Competitive Landscape
30.2. Tetanus Toxoid Vaccine Market Company Profiles
- 30.2.1. Sanofi S.A.
  - 30.2.1.1. Overview
  - 30.2.1.2. Products and Services
  - 30.2.1.3. Strategy
  - 30.2.1.4. Financial Performance
- 30.2.2. Novartis AG
  - 30.2.2.1. Overview
  - 30.2.2.2. Products and Services
  - 30.2.2.3. Strategy
  - 30.2.2.4. Financial Performance
- 30.2.3. LG Chem Ltd.
  - 30.2.3.1. Overview
  - 30.2.3.2. Products and Services
  - 30.2.3.3. Strategy
  - 30.2.3.4. Financial Performance
- 30.2.4. GlaxoSmithKline plc
  - 30.2.4.1. Overview
  - 30.2.4.2. Products and Services
  - 30.2.4.3. Strategy
  - 30.2.4.4. Financial Performance
- 30.2.5. Takeda Pharmaceutical Company Limited
  - 30.2.5.1. Overview
  - 30.2.5.2. Products and Services
  - 30.2.5.3. Strategy
  - 30.2.5.4. Financial Performance

31. Tetanus Toxoid Vaccine Market Other Major And Innovative Companies

31.1. Merck KGaA
31.2. Astellas Pharma Inc.
31.3. CSL Limited
31.4. Zoetis Inc.
31.5. Meiji Holdings Company Ltd.
31.6. Walvax Biotechnology
31.7. Shenzhen Kangtai Biological Products Co. Ltd.
31.8. AJ Vaccines AS
31.9. PT Bio Farma
31.10. Serum Institute of India Pvt. Ltd.
31.11. Bharat Biotech International Limited
31.12. Panacea Biotec Ltd.
31.13. Amson Vaccines and Pharma Pvt Ltd.
31.14. Incepta Vaccine Ltd.
31.15. Mitsubishi Tanabe Pharma Corporation

32. Global Tetanus Toxoid Vaccine Market Competitive Benchmarking

33. Global Tetanus Toxoid Vaccine Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Tetanus Toxoid Vaccine Market

35. Tetanus Toxoid Vaccine Market Future Outlook and Potential Analysis

35.1 Tetanus Toxoid Vaccine Market In 2028 - Countries Offering Most New Opportunities
35.2 Tetanus Toxoid Vaccine Market In 2028 - Segments Offering Most New Opportunities
35.3 Tetanus Toxoid Vaccine Market In 2028 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer